Empowering the Voice of Kansas Pharmacy

Log in

FDA chief has questions, concerns about CBD products

06/03/2019 9:23 AM | Anonymous member (Administrator)

The acting head of the Food and Drug Administration launched the agency’s first hearing on CBD products Friday with a laundry of list of questions about cannabidiol, better known as CBD, which is already being sold in pills, tinctures, skin lotions, sodas and dog food.

How much of the cannabis extract is safe to consume daily, he asked at the jam-packed, all-day hearing at FDA headquarters in Silver Spring. How will it interact with other drugs? What if a consumer is pregnant? What is CBD’s effect on children? What happens if someone takes it over the course of years?

Acting Commissioner Norman “Ned” Sharpless said answers to most of those questions are still unknown despite the popularity of many CBD products.

Read more from the Washington Post.

KPhA appreciates the generous support provided by

Compliant Pharmacy Alliance PBA Health Pharmacists Mutual

Kansas Pharmacists

Preserving, protecting and advancing Kansas pharmacy practice through education, engagement and advocacy.

Contact Us

  • 1020 SW Fairlawn Road
    Topeka, KS 66604
  • 785.228.2327
  • info@ksrx.org
Powered by Wild Apricot Membership Software